Science Explorer Interactive view Map
Company · Menlo Park · United States

NewGen Therapeutics (United States)

newgenther.comROR OpenAlex
Research works
84
▲ 203% vs 2013–17
Citations
2.9k
34.9 per fractional work
Top-10% rate
19.3%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: NewGen Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.47× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 4.63× its world share, 1 worksImmunology and Micro…Neuroscience: 0.89× its world share, 0 worksNeuroscienceChemistry: 0.49× its world share, 0 worksChemistryEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.07× its world share, 0 worksMaterials ScienceHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.94× its world share, 16 worksMedicineVeterinary: 2.93× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.05× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.

Which keywords describe research at NewGen Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Diagnosis, Epidemiology, Immunotherapy, Cancer Immunotherapy, Tumor Regression, Antibiotic Resistance and CAR T Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Epidemiology5▲ 4.2×10 topics
  2. Diagnosis4▲ 17×5 topics
  3. Treatment4▲ 13×6 topics
  4. Immunotherapy3▲ 16×8 topics
  5. Cancer Immunotherapy3▲ 66×3 topics
  6. Tumor Regression3▲ 84×2 topics
  7. Antibiotic Resistance2▲ 23×2 topics
  8. CAR T Cells2▲ 109×1 topic
  9. Chimeric Antigen Receptor2▲ 109×1 topic
  10. Mycobacterium avium2▲ 241×1 topic
  11. Nontuberculous Mycobacteria2▲ 241×1 topic
  12. Immune Response2▲ 13×6 topics
  13. Drug Resistance2▲ 23×3 topics
  14. Gene Therapy2▲ 32×4 topics
  15. Vaccine2▲ 15×4 topics
  16. Genetic Diversity2▲ 13×2 topics
  17. Chemotherapy2▲ 7.5×6 topics
  18. Mycobacterium tuberculosis2▲ 98×1 topic
  19. Tuberculosis2▲ 104×1 topic
  20. Angiogenesis1▲ 15×3 topics
  21. Cancer1▲ 3.7×8 topics
  22. Inflammation1▲ 2.5×8 topics
  23. Cell Signaling1▲ 26×2 topics
  24. Innate Immunity1▲ 12×4 topics
  25. Toll-like Receptors1▲ 35×3 topics
  26. Glycosylation1▲ 33×2 topics
  27. Targeted Therapy1▲ 16×3 topics

Which research topics does NewGen Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Mycobacterium research and diagnosis, Tuberculosis Research and Epidemiology and CRISPR and Genetic Engineering.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMycobacterium research and diagnosis: 2 fractional worksTuberculosis Research and Epidemiology: 2 fractional worksCRISPR and Genetic Engineering: 1 fractional worksVirus-based gene therapy research: 1 fractional worksColorectal Cancer Treatments and Studies: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksProteoglycans and glycosaminoglycans research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksGlycosylation and Glycoproteins Research: 1 fractional works
OncologyEpidemiologyInfectious DiseasesMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Mycobacterium research and diagnosis Epidemiology 2 works
  3. 3 Tuberculosis Research and Epidemiology Infectious Diseases 2 works
  4. 4 CRISPR and Genetic Engineering Molecular Biology 1 works
  5. 5 Virus-based gene therapy research Genetics 1 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 Proteoglycans and glycosaminoglycans research Cell Biology 1 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 1 works
  10. 10 Glycosylation and Glycoproteins Research Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.5%not open52.5%

World: 28% of research is openly available.

with international co-authors26.9%domestic only73.1%

World: 19% is written across borders.

How has NewGen Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 203% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Menlo Park

All research institutions in Menlo Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.